Plassche Douglas 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jul 8, 2025
Insider Transaction Report
Form 4
Plassche Douglas
EVP Operations
Transactions
- Exercise/Conversion
Stock Options (right to buy)
2025-07-03$0.03/sh+2,500,000$75,000→ 2,500,000 total - Exercise/Conversion
Stock Options (right to buy)
2025-07-03−2,500,000→ 5,000,000 totalExercise: $0.03From: 2025-01-03Exp: 2033-01-03→ Common Stock (2,500,000 underlying)
Footnotes (1)
- [F1]All of the stock options were fully vested and exercisable as of the transaction date.